Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantationMihir Raval, Alison Gulbis, Catherine Bollard, et al.
Communications Biology|February 25, 2022
TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse modelIsmail M Meraz, Mourad Majidi, RuPing Shao, et al.
International Journal of Molecular Sciences|July 29, 2023
Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive ImpairmentBojana Milutinovic, Rajasekaran Mahalingam, Mayela Mendt, et al.
Blood|August 19, 2006
Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cellsSiqing Wang, Sungyoul Hong, Jing Yang, et al.
Blood Advances|September 30, 2021
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide eraJason Yeh, Laura Whited, Rima M Saliba, et al.
Frontiers in Oncology|January 27, 2022
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid LeukemiaOren Pasvolsky, May Daher, Gheath Alatrash, et al.
Blood|August 27, 2011
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12Kensuke Kojima, Teresa McQueen, Ye Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysisGabriela Rondón, Rima M Saliba, Issa Khouri, et al.
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityPartow Kebriaei, Susan S Kelly, Pallavi Manuri, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Chronic lymphocytic leukemia: new concepts for future therapyWilliam G Wierda, Nicholas Chiorazzi, Claire Dearden, et al.
Pageof 12